Latest News and Press Releases
Want to stay updated on the latest news?
-
Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
-
Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
-
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
-
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference
-
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
-
Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results
-
Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City
-
Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results
-
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
-
Eledon Announces Tegoprubart Use as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human